ArticleMaternal health, neonatology and perinatology2026
Within- and between-country variation in gestational age thresholds for retinopathy of prematurity screening in Latin America.
Article in Maternal health, neonatology and perinatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesMost Latin American countries have national retinopathy of prematurity (ROP) screening guidelines, but how consistently these thresholds are applied and whether the metric used affects cross-country comparability is poorly documented. SUBJECTS/
methodsWe analysed data from the SPROP (Sociedad Panamericana de Retinopatía del Prematuro) database (2021-2024), including 333 of 343 registrants from 17 countries who provided gestational age (GA) and/or birth weight (BW) screening cutoffs. We assessed between- and within-country variation, guideline concordance, and relative variability of GA and BW thresholds using the coefficient of variation (CV). Hospital-level alignment was classified as wider, at, or narrower than the national guideline.
resultsBW cutoffs were 3.6 to 5.1 times more variable than GA cutoffs across all countries. Mean GA cutoffs approximated national guidelines, but with marked country-level differences: Argentina applied broader cutoffs than recommended (Δ = +1.5 weeks; 50.5% permissive), Colombia and Peru applied narrower cutoffs (Δ = -1.9 and - 1.3 weeks; 62.7% and 45.5% restrictive, respectively). Mexico showed a mixed pattern (63.9% at guideline), and Paraguay had the highest adherence (80.0%). Overall deviation from guideline recommendations (permissive plus restrictive) ranged from 20.0% in Paraguay to 66.3% in Argentina.
conclusionsVariation in concordance with national ROP screening guidelines reflects differences in programme implementation as well as national recommendations. Organisational stewardship, coordinated implementation, and transparent institutional policies may support effective screening, while robust local outcome surveillance is essential to guide evidence-based adaptation and future refinement of screening criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.